drugset / Trial / NCT02958566

Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery

NCT02958566

RandomizedParallel-groupOpen-labelSupportive care

Summary

The General Objective of this study is to investigate the cost and efficacy of treating patients undergoing colorectal surgical resections with an opioid limited pain control regimen as part of an Enhanced Recovery After Surgery (ERAS) Protocol. This group will be compared to a traditional opioid based pain control regimen.

Timeline

Start
2017-01
Primary completion
2017-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 600 mg Oral
Subject Bupivacaine Other / unclassified
Comparator Fentanyl Other / unclassified 50 ug Intravenous
Comparator Fentanyl Other / unclassified 75 ug Intravenous
Subject Gabapentin Small molecule 300 mg Oral
Subject Hydrocodone Unknown 5 mg Oral
Subject Hydrocodone Unknown 325 mg Oral
Comparator Hydromorphone Other / unclassified 0.5 mg Intravenous
Subject Ketamine Small molecule
Subject Ketorolac Other / unclassified 15 mg Intravenous
Subject Lidocaine Other / unclassified 1 mg/kg
Subject Methadone Other / unclassified
Comparator Morphine Other / unclassified 1 mg Intravenous
Comparator Morphine Other / unclassified 2 mg Intravenous
Subject Orphenadrine Small molecule 60 mg Intravenous
Subject Tramadol Other / unclassified 50 mg Oral